These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37113779)

  • 21. Risk of Treatment Failure for Prosthetic Joint Infections: Retrospective Chart Review in an Outpatient Parenteral Antimicrobial Therapy Program.
    Flaten D; Berrigan L; Spirkina A; Gin A
    Can J Hosp Pharm; 2023; 76(1):14-22. PubMed ID: 36683659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Pediatric Outpatient Parenteral Antibiotic Therapy Implementation at a Tertiary Children's Hospital in the United Kingdom.
    Patel S; Burzio V; Green H; Rees S; Tebruegge M; Jones C; Faust SN
    Pediatr Infect Dis J; 2018 Dec; 37(12):e292-e297. PubMed ID: 29613971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.
    Durojaiye OC; Slucka A; Kritsotakis EI
    Eur J Clin Microbiol Infect Dis; 2022 Jun; 41(6):941-949. PubMed ID: 35556187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Inpatient Antimicrobial Regimens for Readmitted Outpatient Parenteral Antimicrobial Therapy Patients Receiving Daptomycin or Ertapenem for Ease of Administration.
    Britt RS; LaSalvia MT; Padival S; Patel P; McCoy C; Mahoney MV
    Open Forum Infect Dis; 2019 Dec; 6(12):ofz496. PubMed ID: 32128338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy.
    Allison GM; Muldoon EG; Kent DM; Paulus JK; Ruthazer R; Ren A; Snydman DR
    Clin Infect Dis; 2014 Mar; 58(6):812-9. PubMed ID: 24357220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twice daily cefazolin is effective for treatment of serious methicillin-sensitive
    Birrell MT; Fuller A
    Ther Adv Infect Dis; 2019; 6():2049936119882847. PubMed ID: 31839941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The first trial of OPAT (outpatient parenteral antimicrobial therapy) with continuous infusions in Japan].
    Hase R; Hosokawa N; Uno S; Mikawa T; Uwamino Y; Muranaka K
    Kansenshogaku Zasshi; 2014 May; 88(3):269-74. PubMed ID: 24974449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Huang V; Ruhe JJ; Lerner P; Fedorenko M
    BMC Pharmacol Toxicol; 2018 Aug; 19(1):50. PubMed ID: 30081959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.
    Durojaiye OC; Bell H; Andrews D; Ntziora F; Cartwright K
    Int J Antimicrob Agents; 2018 Jan; 51(1):26-32. PubMed ID: 28673610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic Foot Infection and Select Comorbidities Drive Readmissions in Outpatient Parenteral Antimicrobial Therapy.
    Barnes A; Nunez M
    Am J Med Sci; 2021 Feb; 361(2):233-237. PubMed ID: 33097196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service.
    Mackintosh CL; White HA; Seaton RA
    J Antimicrob Chemother; 2011 Feb; 66(2):408-15. PubMed ID: 21118914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program.
    Quintens C; Steffens E; Jacobs K; Schuermans A; Van Eldere J; Lagrou K; De Munter P; Derdelinckx I; Peetermans WE; Spriet I
    Infection; 2020 Jun; 48(3):357-366. PubMed ID: 32060859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center.
    Epperson TM; Bennett KK; Kupiec KK; Speigel K; Neely SB; Resman-Targoff BH; Kinney KK; White BP
    Antimicrob Steward Healthc Epidemiol; 2023; 3(1):e15. PubMed ID: 36714295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outpatient parenteral antibiotic therapy in a suburban tertiary referral centre in Australia over 10 years.
    Li W; Branley J; Sud A
    Infection; 2018 Jun; 46(3):349-355. PubMed ID: 29464675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-administered outpatient parenteral antimicrobial therapy: a report of three years experience in the Irish healthcare setting.
    Kieran J; O'Reilly A; Parker J; Clarke S; Bergin C
    Eur J Clin Microbiol Infect Dis; 2009 Nov; 28(11):1369-74. PubMed ID: 19697069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.
    Durojaiye OC; Kritsotakis EI; Johnston P; Kenny T; Ntziora F; Cartwright K
    Clin Microbiol Infect; 2019 Jul; 25(7):905.e1-905.e7. PubMed ID: 30502491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient parenteral antimicrobial therapy with continuous infusion of meropenem: A retrospective analysis of three years of clinical experience.
    Dubois-Silva Á; Otero-Plaza L; Dopico-Santamariña L; Mozo-Ríos A; Hermida-Porto L; Feal-Cortizas B; García-Queiruga M; Pértega-Díaz S; Lamelo-Alfonsín F; Vidán-Martínez L
    Enferm Infecc Microbiol Clin (Engl Ed); 2023; 41(6):321-328. PubMed ID: 36610829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OPAT in Switzerland: single-center experience of a model to treat complicated infections.
    Erba A; Beuret M; Daly ML; Khanna N; Osthoff M
    Infection; 2020 Apr; 48(2):231-240. PubMed ID: 31828605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of Outpatient Parenteral Antimicrobial Therapy in Children.
    Fernandes P; Milliren C; Mahoney-West HM; Schwartz L; Lachenauer CS; Nakamura MM
    Pediatr Infect Dis J; 2018 Feb; 37(2):157-163. PubMed ID: 28763427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.